Likewise, conflicting results were also reported in laboratory studies investigating whether or not GLP-1 receptor agonists caused inflammation in pancreatic tissue and promoted proliferation in pancreatic cancer cells [7,30,31]. Here, GLP1R is linked to familial pancreatic carcinoma.